Abstract
There are signs that the therapeutic successes that have contributed to the downward trajectory for HIV-1 mortality may soon be repeated for HCV.
Links
Source
Nature reviews. Microbiology 10:5 2012 May pg 307MeSH
Antiviral AgentsDrug Therapy
Hepacivirus
Hepatitis C
Humans
Incidence
Survival Analysis
Treatment Outcome
Pub Type(s)
EditorialLanguage
eng
PubMed ID
22629548
Log In

